Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis-Reference-Cited by-同舟云学术

Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis

Published:2022-04 Issue:4 Volume:20 Page:1008-1014
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Kelliher Sarah^ORCID,Weiss Luisa^ORCID,Cullivan Sarah,O’Rourke Ellen,Murphy Claire A.,Toolan Shane,Lennon Áine,Szklanna Paulina B.,Comer Shane P.^ORCID,Macleod Hayley,Le Chevillier Ana,Gaine Sean,O’Reilly Kate M.A.,McCullagh Brian,Stack John,Maguire Patricia B.,Ní Áinle Fionnuala^ORCID,Kevane Barry^ORCID

Funder

Science Foundation Ireland

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15660

Reference30 articles.

1. Coagulopathy in COVID‐19;Iba;J Thromb Haemost,2020

2. COVID‐19 and coagulation: bleeding and thrombotic manifestations of SARS‐CoV‐2 infection;Al‐Samkari;Blood,2020

3. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia;Tang;J Thromb Haemost,2020